Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Saisamkalpa Mantrala
Institution:
VA Northern California Health Care System
Observed institution:
VA Northern California Health Care System
ORCID:
0009-0001-4463-8765
Observed ORCID:
0009-0001-4463-8765
OpenAlex ID:
A5092471963
Pesticides and Bladder Cancer: Mechanisms Leading to Anti-Cancer Drug Chemoresistance and New Chemosensitization Strategies
2023
·
Christopher A. Lucchesi
, Demitria M. Vasilatis
, et al.
·
International Journal of Molecular Sciences
·
20
PDF
ANGEL2 Modulates Wild-type TP53 Translation and Doxorubicin Chemosensitivity in Colon Cancer
2025
·
Christopher August Lucchesi
, Saisamkalpa Mantrala
, et al.
·
Molecular Cancer Research
·
2
Figure S1 from ANGEL2 Modulates Wild-type TP53 Translation and Doxorubicin Chemosensitivity in Colon Cancer
2025
·
Christopher August Lucchesi
, Saisamkalpa Mantrala
, et al.
Figure S2 from ANGEL2 Modulates Wild-type TP53 Translation and Doxorubicin Chemosensitivity in Colon Cancer
2025
·
Christopher August Lucchesi
, Saisamkalpa Mantrala
, et al.
Figure S4 from ANGEL2 Modulates Wild-type TP53 Translation and Doxorubicin Chemosensitivity in Colon Cancer
2025
·
Christopher August Lucchesi
, Saisamkalpa Mantrala
, et al.
Data from ANGEL2 Modulates Wild-type TP53 Translation and Doxorubicin Chemosensitivity in Colon Cancer
2025
·
Christopher August Lucchesi
, Saisamkalpa Mantrala
, et al.
Figure S3 from ANGEL2 Modulates Wild-type TP53 Translation and Doxorubicin Chemosensitivity in Colon Cancer
2025
·
Christopher August Lucchesi
, Saisamkalpa Mantrala
, et al.
Supplemental Figure Legends from ANGEL2 Modulates Wild-type TP53 Translation and Doxorubicin Chemosensitivity in Colon Cancer
2025
·
Christopher August Lucchesi
, Saisamkalpa Mantrala
, et al.
Show more works
View as search
Works count:
8
Citation count:
25
H-index:
2
I10-index:
1
Year
Topic
Type